ImageneBio Inc(IMA)

Biotechnology · San Diego, CA

$4.76+0.05 (+1.17%)

Delayed quote: Oct 6, 2026, 12:31 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:07:25.760Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:07:25.760Z.

Quote observation: 2026-10-06T16:31:24.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 4.755
Unrounded diluted TTM EPS · period ending 2026-06-30: -5.21

FMP input reference: 3f3fe5cfad96663d45aee285232b63282d401ce5a2dce1ebe999e7f7af3a8937

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

IMA PE Ratio Metrics

PE RATIO

N/A

IMA Competitors' PE Ratio

IMA

ImageneBio Inc

Current

Market Cap

$53.63M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs IMA

Market Cap

$53.39M

PE Ratio

N/A

TTM Avg

2.27

3Y Avg

2.27

5Y Avg

2.27

MDAI

Spectral AI, Inc.

vs IMA

Market Cap

$54.10M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDSB

PDS Biotechnology Corporation

vs IMA

Market Cap

$54.16M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs IMA

Market Cap

$52.78M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs IMA

Market Cap

$52.46M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs IMA

Market Cap

$51.83M

PE Ratio

10.07

TTM Avg

4.82

3Y Avg

27.98

5Y Avg

18.54

EXOZ

eXoZymes, Inc.

vs IMA

Market Cap

$51.42M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs IMA

Market Cap

$51.33M

PE Ratio

N/A

TTM Avg

135.17

3Y Avg

135.17

5Y Avg

135.17

RANI

Rani Therapeutics Holdings, Inc.

vs IMA

Market Cap

$50.99M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
ImageneBio Inc (IMA)	$53.63M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$53.39M	N/A	2.27	2.27	2.27
Spectral AI, Inc. (MDAI)vs ›	$54.10M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$54.16M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$52.78M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.46M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.83M	10.07	4.82	27.98	18.54
eXoZymes, Inc. (EXOZ)vs ›	$51.42M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	135.17	135.17	135.17
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$50.99M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$4.75

Forward EPS (Est.)

$-3.22

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

IMA PE Ratio Metrics

IMA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics